Xopenex and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Xopenex (levalbuterol hydrochloride), especially for people who are female, 60+ old, also take Synthroid, and have Primary immunodeficiency syndrome.

The phase IV clinical study analyzes which people have Ipf when taking Xopenex. It is created by eHealthMe based on reports of 13,420 people who have side effects when taking Xopenex from the FDA, and is updated regularly.

What is Xopenex?

Xopenex has active ingredients of levalbuterol hydrochloride. It is often used in asthma. eHealthMe is studying from 13,816 Xopenex users. Check the latest studies of Xopenex.

What is Ipf?

Ipf is found to be associated with 1,832 drugs and 2,263 conditions by eHealthMe. Check the latest studies of Ipf.

On Jan, 10, 2026

13,420 people reported to have side effects when taking Xopenex.
Among them, 31 people (0.23%) have Ipf.

Among these 31 people:

What is the gender of people who have Ipf when taking Xopenex? *

female: 61.29 %
male: 38.71 %

What is the age of people who have Ipf when taking Xopenex? *

What are other drugs people take besides Xopenex? *

What are other side effects people have besides Ipf? *

Pneumonia: 11 people, 35.48%
Dyspnea (difficult or laboured breathing): 11 people, 35.48%
Skin Discoloration: 8 people, 25.81%
Fall: 7 people, 22.58%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 7 people, 22.58%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 22.58%
Headache (pain in head): 6 people, 19.35%
Celiac Disease - Sprue (a disease of the small intestine): 5 people, 16.13%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 5 people, 16.13%
Peripheral Swelling: 5 people, 16.13%

What are the existing conditions these people have? *

Primary Immunodeficiency Syndrome: 5 people, 16.13%
Immunodeficiency Common Variable: 3 people, 9.68%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 6.45%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 6.45%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 2 people, 6.45%
Substance-Induced Psychotic Disorder: 1 person, 3.23%
Depression: 1 person, 3.23%
Fungal Skin Infection: 1 person, 3.23%
Dyspnea (difficult or laboured breathing): 1 person, 3.23%
Dry Mouth: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Xopenex and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xopenex:

Xopenex (13,816 reports)

Ipf treatments and more:

Ipf (79,193 reports)

Browse all side effects of Xopenex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,832 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,263 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levalbuterol hydrochloride (the active ingredients of Xopenex) and Xopenex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.